Tema ETFs LLC increased its holdings in shares of Cognex Corporation (NASDAQ:CGNX – Free Report) by 3.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 320,678 shares of the scientific and technical instruments company’s stock after acquiring an additional 11,988 shares during the period. Tema ETFs LLC owned approximately 0.19% of Cognex worth $23,224,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Sax Wealth Advisors LLC purchased a new position in shares of Cognex during the second quarter valued at approximately $475,000. Hennion & Walsh Asset Management Inc. grew its stake in shares of Cognex by 65.6% in the 2nd quarter. Hennion & Walsh Asset Management Inc. now owns 19,432 shares of the scientific and technical instruments company’s stock worth $1,407,000 after buying an additional 7,701 shares during the last quarter. Gradient Investments LLC bought a new position in Cognex during the 2nd quarter valued at approximately $1,012,000. FNY Investment Advisers LLC purchased a new position in Cognex during the second quarter valued at $45,000. Finally, Elevation Wealth Partners LLC boosted its holdings in Cognex by 635.4% in the second quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company’s stock worth $35,000 after acquiring an additional 413 shares in the last quarter. Hedge funds and other institutional investors own 88.12% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the company. Needham & Company LLC raised their price target on Cognex from $75.00 to $80.00 and gave the company a “buy” rating in a report on Friday, August 7th. Zacks Research upgraded shares of Cognex from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, June 16th. Robert W. Baird set a $72.00 target price on shares of Cognex in a research note on Friday, May 8th. Cantor Fitzgerald raised their price target on shares of Cognex from $76.00 to $84.00 and gave the company an “overweight” rating in a research report on Friday, August 7th. Finally, Wall Street Zen lowered shares of Cognex from a “buy” rating to a “hold” rating in a report on Saturday. Two equities research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $75.64.
Insider Activity at Cognex
In other news, VP Darren Marc Long sold 20,252 shares of the stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total value of $1,343,517.68. Following the transaction, the vice president owned 3,990 shares in the company, valued at $264,696.60. This represents a 83.54% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.70% of the stock is owned by insiders.
Cognex Trading Down 2.3%
Shares of CGNX stock opened at $62.90 on Wednesday. Cognex Corporation has a 12-month low of $34.60 and a 12-month high of $72.88. The stock has a market capitalization of $10.58 billion, a P/E ratio of 61.07 and a beta of 1.49. The firm’s 50 day moving average is $64.94 and its 200 day moving average is $57.61.
Cognex (NASDAQ:CGNX – Get Free Report) last announced its earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, beating analysts’ consensus estimates of $0.42 by $0.03. Cognex had a net margin of 16.05% and a return on equity of 13.50%. The business had revenue of $291.26 million during the quarter, compared to analyst estimates of $292.10 million. During the same period in the previous year, the business earned $0.25 EPS. The company’s quarterly revenue was up 16.9% compared to the same quarter last year. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. As a group, equities analysts predict that Cognex Corporation will post 1.67 earnings per share for the current year.
Cognex Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Shareholders of record on Thursday, August 20th will be paid a dividend of $0.085 per share. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Thursday, August 20th. Cognex’s payout ratio is currently 33.01%.
About Cognex
Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.
The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.
See Also
- Five stocks we like better than Cognex
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.
